· investment-strategies · 6 min read
Most Active NYC Startup Investors 2024–2026: Who’s Writing Checks Now
A methodology-backed map of the most visible NYC startup investors by public deal activity from 2024 through mid-2026 — with caveats, fund links, and recent deal examples.
Short answer (as of July 2026): The most visible active NYC startup investors from 2024 through mid-2026 are BoxGroup, Lerer Hippeau, Primary Venture Partners, Greycroft, and Contour Venture Partners for early-stage deal frequency — with Thrive Capital, Lux Capital, Insight Partners, and Union Square Ventures showing high-signal but lower-volume activity. This is not an official PitchBook ranking; it is a public-rounds activity map with stated caveats.
Methodology
We rank visibility of check-writing, not returns or AUM.
| Signal | What we count | What we do not count |
|---|---|---|
| Public round appearances | Named investor on a disclosed NYC-company raise (press, AlleyWatch, company blog) | Silent LPs, secondary purchases, undisclosed SAFEs |
| Lead vs participate | Leads weighted higher in qualitative “activity signal” | Being named on a mega-round alone ≠ highest activity |
| Window | Calendar 2024 → H1 2026, with Q2 2026 AlleyWatch as the freshest quarterly cut | Lifetime reputation alone (except as context) |
| Geography | NYC HQ firms or firms repeatedly on NYC company caps | One-off SF fund co-invests without a NYC pattern |
Primary sources for counts: AlleyWatch NYC Funding Index — most active all-time and AlleyWatch Q2 2026 NYC funding report (BoxGroup #1 with 9 Q2 deals). Fund sizes and named rounds from TechCrunch, Business Wire, Isomorphic Labs, and firm announcements (linked in Sources).
Data caveats (read before citing)
- Public rounds are incomplete. Many seed SAFEs and insider rounds never hit AlleyWatch or TechCrunch. Real activity is higher than visible activity.
- Deal count ≠ capital deployed. BoxGroup’s many small checks look “more active” than Thrive writing one $2B-led Series B. Both matter for different founder jobs.
- National platforms inflate NYC lists. Y Combinator, a16z, General Catalyst, and Index appear near the top of quarterly NYC deal tables because they invest in NYC companies — they are not NYC-HQ seed specialists.
- No PitchBook / CB Insights paid export was used. Do not treat this page as an official market rank. Figures below labeled “approx.” are qualitative bands from public visibility.
- Late reporting revises totals. AlleyWatch itself notes quarterly figures can move as late-reported rounds are added.
Most visible active NYC investors, 2024–2026
Qualitative activity signal = frequency of public NYC-company appearances + evidence of fresh dry powder / recent leads. Ordered for founder shortlisting by who is writing checks now, not by AUM (for AUM see NYC top 15 by AUM).
| Rank | Firm | Stage (typical) | Activity signal (2024–H1 2026) | Example recent / notable deals (sourced) |
|---|---|---|---|---|
| 1 | BoxGroup | Pre-seed / seed | Very high — #1 AlleyWatch Q2 2026 NYC investor (9 deals); #2 all-time NYC index (~270 deals) | Broad ultra-early participation across NYC SaaS/fintech/AI; rarely sole lead |
| 2 | Lerer Hippeau | Seed | Very high — #1 all-time AlleyWatch NYC index (~319 deals); consistent seed volume | Brami $33M Series B participant (May 2026); long consumer + SaaS book |
| 3 | Primary Venture Partners | Pre-seed / seed lead | Very high — $625M Fund V (Feb 2026); targeting ~40–50 companies / 3 years | Windmill seed ( |
| 4 | Greycroft | Seed → growth | High — $1B+ new fund commitments; dual NY/LA platform | Led Jesse & Ben’s $10M Series A and Recursive Superintelligence Series A (May 2026) |
| 5 | Contour Venture Partners | Seed / early A | High — durable NYC B2B/fintech seed presence; ~92 all-time AlleyWatch NYC deals | Compyl $12M Series A co-investor (2025); classic NYC SaaS seed lead pattern |
| 6 | Union Square Ventures | Seed / A (thesis) | High (selective) — ~118 all-time NYC deals; lower volume, high conviction | Thesis-driven AI + networks; fewer spray rounds than seed volume shops |
| 7 | Work-Bench | Seed (enterprise B2B) | High (focused) — enterprise-only; steady seed leads into Fortune 500 GTM | Enterprise infra / security / data; see firm portfolio (Cockroach Labs era alumni network) |
| 8 | Boldstart Ventures | Inception / pre-seed | High — $250M Fund VII (Jul 2025); 15+ new teams in 2025 recap | Keycard inception + Series A (2025, co-led inception with a16z); Protect AI exit path |
| 9 | Lux Capital | Early / deep tech | High-signal — fewer deals, large tickets in frontier science | Flourish $500M (Jun 2026) with Bezos + GV — SoHo brain-inspired AI lab |
| 10 | Thrive Capital | Multi-stage / crossover | High-signal — low deal count, mega-round leadership | Isomorphic Labs $600M (2025) then $2.1B Series B led May 2026 |
| 11 | Insight Partners | Growth / ScaleUp | Steady growth — ~107 all-time AlleyWatch NYC deals; software buy-and-build | Mid-market software growth + follow-ons (not a seed lead) |
Also visible on NYC caps (name in prose only — no /fund/ page here): FirstMark, RRE Ventures, AlleyCorp, Bowery Capital, Bloomberg Beta, Y Combinator, General Catalyst, a16z, Index. See our early-stage A–Z and 2026 seed market guide.
Quarterly notes (2024 → mid-2026)
- 2024: Stabilization year for NYC dollars (~$15.1B full-year per AlleyWatch historical table in the Q2 2026 report). Seed volume shops (Lerer, BoxGroup, Contour, Primary) stayed the day-to-day check writers while growth stayed selective.
- 2025: Recovery (~$19.1B NYC full-year per AlleyWatch). Boldstart closed Fund VII ($250M, July 2025). Greycroft raised $1B+ across new vehicles. Thrive led Isomorphic’s first external $600M round.
- H1 2026: NYC raised $17.7B across 504 deals (AlleyWatch) — already near 2025’s full-year total. Q2 2026: $8.88B / 233 deals; BoxGroup topped the quarterly investor table. Primary’s Fund V began deploying at $5–10M average checks (TechCrunch). Lux and Thrive showed up on frontier / mega AI financings rather than seed volume lists.
Track daily flow via AlleyWatch’s daily funding reports.
Founder take
- If you need a seed lead in NYC this quarter: Prioritize Primary, Lerer Hippeau, Contour, Work-Bench (enterprise), Boldstart (technical inception), and add BoxGroup as a high-probability participant — not usually the sole lead.
- If you are raising growth / multi-stage: Thrive and Insight are active but picky; activity signal is capital + category power, not weekly seed volume.
- If you are deep tech / frontier: Lux and USV’s thesis filter matter more than raw deal counts.
- Do not confuse “most active” with “best for you.” Pitch the partner who owns your sector, then use activity data to confirm they are still deploying.
Related reading
- NYC seed-stage map 2026
- NYC top 15 VC firms by AUM
- Primary Fund V playbook
- Thrive Capital overview
- Insight Partners playbook
- Venture capital firms in NYC directory intro
Sources
- AlleyWatch — Most Active NYC Startup Investors (all-time index): https://funding.alleywatch.com/nyc-most-active-investors
- AlleyWatch — NYC Q2 2026 funding report ($8.88B; BoxGroup 9 deals): https://alleywatch.com/2026/07/nyc-startup-funding-q2-2026-best-capital-quarter-since-2021/
- AlleyWatch — June 2026 NYC VC report (Flourish / Ramp context): https://alleywatch.com/2026/07/new-york-venture-capital-june-2026/
- TechCrunch — Primary Ventures $625M Fund V (Feb 10, 2026): https://techcrunch.com/2026/02/10/primary-ventures-raises-massive-625m-fund-v-to-focus-on-seed-investing/
- Isomorphic Labs — $2.1B Series B led by Thrive (May 12, 2026): https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round
- Business Wire — Boldstart Fund VII $250M (July 8, 2025): https://www.businesswire.com/news/home/20250708927572/en/
- Crunchbase News — Greycroft $1B+ new funds: https://news.crunchbase.com/startups/greycroft-venture-funding-ai-goop-brds/
- Primary.vc / aggregator deal notes (Windmill, Haiqu, Biological Computing — treat sizes as approximate until company press confirms): https://www.primary.vc/
- 2026-vc-news
- venture-capital
- nyc-startups
- +3 more